Guimbellot JS - Search Results

1

Efficient intracellular processing of the endogenous cystic fibrosis transmembrane conductance regulator in epithelial cell lines.

Varga K, Jurkuvenaite A, Wakefield J, Hong JS, Guimbellot JS, Venglarik CJ, Niraj A, Mazur M, Sorscher EJ, Collawn JF, Bebök Z. Varga K, et al. Among authors: guimbellot js. J Biol Chem. 2004 May 21;279(21):22578-84. doi: 10.1074/jbc.M401522200. Epub 2004 Apr 1. J Biol Chem. 2004. PMID: 15066992 Free article.

2

Role of oxygen availability in CFTR expression and function.

Guimbellot JS, Fortenberry JA, Siegal GP, Moore B, Wen H, Venglarik C, Chen YF, Oparil S, Sorscher EJ, Hong JS. Guimbellot JS, et al. Am J Respir Cell Mol Biol. 2008 Nov;39(5):514-21. doi: 10.1165/rcmb.2007-0452OC. Epub 2008 May 12. Am J Respir Cell Mol Biol. 2008. PMID: 18474670 Free PMC article.

3

Correlation of microRNA levels during hypoxia with predicted target mRNAs through genome-wide microarray analysis.

Guimbellot JS, Erickson SW, Mehta T, Wen H, Page GP, Sorscher EJ, Hong JS. Guimbellot JS, et al. BMC Med Genomics. 2009 Mar 25;2:15. doi: 10.1186/1755-8794-2-15. BMC Med Genomics. 2009. PMID: 19320992 Free PMC article.

4

Toward inclusive therapy with CFTR modulators: Progress and challenges.

Guimbellot J, Sharma J, Rowe SM. Guimbellot J, et al. Pediatr Pulmonol. 2017 Nov;52(S48):S4-S14. doi: 10.1002/ppul.23773. Epub 2017 Sep 7. Pediatr Pulmonol. 2017. PMID: 28881097 Free PMC article. Review.

5

Human Nasal Epithelial Organoids for Therapeutic Development in Cystic Fibrosis.

Liu Z, Anderson JD, Deng L, Mackay S, Bailey J, Kersh L, Rowe SM, Guimbellot JS. Liu Z, et al. Among authors: guimbellot js. Genes (Basel). 2020 May 29;11(6):603. doi: 10.3390/genes11060603. Genes (Basel). 2020. PMID: 32485957 Free PMC article.

6

Culture and Imaging of Human Nasal Epithelial Organoids.

Liu Z, Anderson JD, Natt J, Guimbellot JS. Liu Z, et al. Among authors: guimbellot js. J Vis Exp. 2021 Dec 17;(178):10.3791/63064. doi: 10.3791/63064. J Vis Exp. 2021. PMID: 34978285 Free PMC article.

7

Plasma and cellular ivacaftor concentrations in patients with cystic fibrosis.

Guimbellot JS, Ryan KJ, Anderson JD, Parker KL, Victoria Odom L, Rowe SM, Acosta EP. Guimbellot JS, et al. Pediatr Pulmonol. 2022 Nov;57(11):2745-2753. doi: 10.1002/ppul.26093. Epub 2022 Aug 17. Pediatr Pulmonol. 2022. PMID: 35927224 Free PMC article.

8

Prime editing-mediated correction of the CFTR W1282X mutation in iPSCs and derived airway epithelial cells.

Li C, Liu Z, Anderson J, Liu Z, Tang L, Li Y, Peng N, Chen J, Liu X, Fu L, Townes TM, Rowe SM, Bedwell DM, Guimbellot J, Zhao R. Li C, et al. PLoS One. 2023 Nov 29;18(11):e0295009. doi: 10.1371/journal.pone.0295009. eCollection 2023. PLoS One. 2023. PMID: 38019847 Free PMC article.

9

Effectiveness of ivacaftor in cystic fibrosis patients with non-G551D gating mutations.

Guimbellot J, Solomon GM, Baines A, Heltshe SL, VanDalfsen J, Joseloff E, Sagel SD, Rowe SM; GOALe(2) Investigators. Guimbellot J, et al. J Cyst Fibros. 2019 Jan;18(1):102-109. doi: 10.1016/j.jcf.2018.04.004. Epub 2018 Apr 21. J Cyst Fibros. 2019. PMID: 29685811 Free PMC article.

10

Variable cellular ivacaftor concentrations in people with cystic fibrosis on modulator therapy.

Guimbellot JS, Ryan KJ, Anderson JD, Liu Z, Kersh L, Esther CR, Rowe SM, Acosta EP. Guimbellot JS, et al. J Cyst Fibros. 2020 Sep;19(5):742-745. doi: 10.1016/j.jcf.2020.01.011. Epub 2020 Feb 7. J Cyst Fibros. 2020. PMID: 32044246 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page